Literature DB >> 21030011

Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage.

Kevin O Saunders1, Cavin Ward-Caviness, Robert J Schutte, Stephanie A Freel, R Glenn Overman, Nathan M Thielman, Coleen K Cunningham, Thomas B Kepler, Georgia D Tomaras.   

Abstract

CD8(+) T-lymphocytes can utilize noncytolytic mechanisms to suppress HIV-1 replication through the secretion of soluble factors. The secretion of MIP-1β, MIP-1α, IP-10, MIG, IL-1α, and interferon gamma correlated most strongly with soluble noncytolytic suppression (p<0.0001). Since the noncytolytic response is impaired by histone hyperacetylation, we examined the ability of histone hyperacetylation to alter the expression of immune-related genes. MIP-1α and IP-10 were also among the genes that were down-regulated by histone hyperacetylation. We define a multifactorial cytokine profile of CD8(+) T-lymphocytes capable of mediating noncytolytic suppression of CXCR4-tropic HIV-1 replication.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030011      PMCID: PMC3615706          DOI: 10.1016/j.cellimm.2010.09.011

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  65 in total

1.  Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.

Authors:  Stephanie A Freel; Laurie Lamoreaux; Pratip K Chattopadhyay; Kevin Saunders; David Zarkowsky; R Glenn Overman; Christina Ochsenbauer; Tara G Edmonds; John C Kappes; Coleen K Cunningham; Thomas N Denny; Kent J Weinhold; Guido Ferrari; Barton F Haynes; Richard A Koup; Barney S Graham; Mario Roederer; Georgia D Tomaras
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

2.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

3.  CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Authors:  Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

4.  In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Authors:  Joseph K Wong; Matthew C Strain; Rodin Porrata; Elizabeth Reay; Sumathi Sankaran-Walters; Caroline C Ignacio; Theresa Russell; Satish K Pillai; David J Looney; Satya Dandekar
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

5.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.

Authors:  C M Walker; A L Erickson; F C Hsueh; J A Levy
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.

Authors:  Brinda Emu; Elizabeth Sinclair; Hiroyu Hatano; April Ferre; Barbara Shacklett; Jeffrey N Martin; J M McCune; Steven G Deeks
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.

Authors:  Y Su; W Popik; P M Pitha
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor.

Authors:  J E Brinchmann; G Gaudernack; F Vartdal
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

10.  Initiation of human immunodeficiency virus type 1 (HIV-1) transcription is inhibited by noncytolytic CD8 suppression.

Authors:  R Glenn Overman; Anthony L Llorens; Michael L Greenberg; Mariano A Garcia-Blanco; Georgia D Tomaras
Journal:  Open Virol J       Date:  2007-08-13
View more
  17 in total

1.  Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.

Authors:  Stephanie A Freel; Ralph A Picking; Guido Ferrari; Haitao Ding; Christina Ochsenbauer; John C Kappes; Jennifer L Kirchherr; Kelly A Soderberg; Kent J Weinhold; Coleen K Cunningham; Thomas N Denny; John A Crump; Myron S Cohen; Andrew J McMichael; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

Review 2.  Endemic Viruses of Squirrel Monkeys (Saimiri spp.).

Authors:  Donna L Rogers; Gloria B McClure; Julio C Ruiz; Christian R Abee; John A Vanchiere
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

Review 3.  CD8(+)T-cell-mediated control of HIV-1 and SIV infection.

Authors:  Stephanie A Freel; Kevin O Saunders; Georgia D Tomaras
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection.

Authors:  Marc A Frahm; Ralph A Picking; JoAnn D Kuruc; Kara S McGee; Cynthia L Gay; Joseph J Eron; Charles B Hicks; Georgia D Tomaras; Guido Ferrari
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

5.  Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.

Authors:  Gabriela Turk; Yanina Ghiglione; Juliana Falivene; María Eugenia Socias; Natalia Laufer; Romina Soledad Coloccini; Ana María Rodriguez; María Julia Ruiz; María Ángeles Pando; Luis David Giavedoni; Pedro Cahn; Omar Sued; Horacio Salomon; María Magdalena Gherardi
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

6.  Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition.

Authors:  Tamika L Payne; Jeff Blackinton; Alyse Frisbee; Joy Pickeral; Sheetal Sawant; Nathan A Vandergrift; Stephanie A Freel; Guido Ferrari; Jack D Keene; Georgia D Tomaras
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.

Authors:  Mary K McKenna; Alexander Englisch; Benjamin Brenner; Tyler Smith; Valentina Hoyos; Masataka Suzuki; Malcolm K Brenner
Journal:  Mol Ther       Date:  2021-02-09       Impact factor: 11.454

8.  Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.

Authors:  Guido Ferrari; Bette Korber; Nilu Goonetilleke; Michael K P Liu; Emma L Turnbull; Jesus F Salazar-Gonzalez; Natalie Hawkins; Steve Self; Sydeaka Watson; Michael R Betts; Cynthia Gay; Kara McGhee; Pierre Pellegrino; Ian Williams; Georgia D Tomaras; Barton F Haynes; Clive M Gray; Persephone Borrow; Mario Roederer; Andrew J McMichael; Kent J Weinhold
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

9.  Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.

Authors:  Luca Genovese; Manuela Nebuloni; Massimo Alfano
Journal:  Front Immunol       Date:  2013-04-09       Impact factor: 7.561

10.  Heme oxygenase-1 induction alters chemokine regulation and ameliorates human immunodeficiency virus-type-1 infection in lipopolysaccharide-stimulated macrophages.

Authors:  Zhao-Hua Zhou; Namita Kumari; Sergei Nekhai; Kathleen A Clouse; Larry M Wahl; Kenneth M Yamada; Subhash Dhawan
Journal:  Biochem Biophys Res Commun       Date:  2013-05-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.